Büller HR - Search Results

1

Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.

Raskob G, Ageno W, Cohen AT, Brekelmans MP, Grosso MA, Segers A, Meyer G, Verhamme P, Wells PS, Lin M, Winters SM, Weitz JI, Büller HR. Raskob G, et al. Among authors: buller hr. Lancet Haematol. 2016 May;3(5):e228-36. doi: 10.1016/S2352-3026(16)00023-5. Epub 2016 Mar 22. Lancet Haematol. 2016. PMID: 27132697 Clinical Trial.

2

Direct thrombin inhibitors in acute coronary syndromes: present and future.

Weitz JI, Buller HR. Weitz JI, et al. Among authors: buller hr. Circulation. 2002 Feb 26;105(8):1004-11. doi: 10.1161/hc0802.104331. Circulation. 2002. PMID: 11864933 Review. No abstract available.

3

Treatment of symptomatic venous thromboembolism: improving outcomes.

Büller HR. Büller HR. Semin Thromb Hemost. 2002 Jun;28 Suppl 2:41-8. doi: 10.1055/s-2002-32315. Semin Thromb Hemost. 2002. PMID: 12073179 Review.

4

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR. Strebel N, et al. Among authors: buller hr. Arch Intern Med. 2002 Jul 8;162(13):1451-6. doi: 10.1001/archinte.162.13.1451. Arch Intern Med. 2002. PMID: 12090880 Review.

5

Travel and the risk of symptomatic venous thromboembolism.

ten Wolde M, Kraaijenhagen RA, Schiereck J, Hagen PJ, Mathijssen JJ, Mac Gillavry MR, Koopman MM, Büller HR. ten Wolde M, et al. Among authors: buller hr. Thromb Haemost. 2003 Mar;89(3):499-505. Thromb Haemost. 2003. PMID: 12624634

6

The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.

van Dongen CJ, Vink R, Hutten BA, Büller HR, Prins MH. van Dongen CJ, et al. Among authors: buller hr. Arch Intern Med. 2003 Jun 9;163(11):1285-93. doi: 10.1001/archinte.163.11.1285. Arch Intern Med. 2003. PMID: 12796064

7

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators. Büller HR, et al. Ann Intern Med. 2004 Jun 1;140(11):867-73. doi: 10.7326/0003-4819-140-11-200406010-00007. Ann Intern Med. 2004. PMID: 15172900 Clinical Trial.

8

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Büller HR, et al. Chest. 2004 Sep;126(3 Suppl):401S-428S. doi: 10.1378/chest.126.3_suppl.401S. Chest. 2004. PMID: 15383479 Review.

9

Duration of warfarin in pulmonary embolism.

Miller A, Campbell I, Fennerty T, Raskob GE, Büller HR. Miller A, et al. Among authors: buller hr. Chest. 2006 Jul;130(1):299; author reply 299-300. doi: 10.1378/chest.130.1.299. Chest. 2006. PMID: 16840417 No abstract available.

10

Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study.

Squizzato A, Romualdi E, Piantanida E, Gerdes VE, Büller HR, Tanda M, Bartalena L, Venco A, Ageno W. Squizzato A, et al. Among authors: buller hr. Thromb Haemost. 2007 May;97(5):803-6. Thromb Haemost. 2007. PMID: 17479191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page